Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122284) titled 'Exploring MRPL16 as a diagnostic and prognostic marker for perioperative heart failure in diabetic patients: a clinical study' on April 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Nanjing Drum Tower Hospital
Condition:
T2DM
Intervention:
HFrEF+T2DM:N/A
HFpEF+T2DM:N/A
HFpEF-T2DM:N/A
HFrEF-T2DM:N/A
T2DM:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-30
Target Sample Size: HFrEF+T2DM:80;HFpEF+T2DM:80;HFpEF-T2DM:80;HFrEF-T2DM:80;T2DM:40;Healthy control:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.o...